SCHEMBL7687130

SCHEMBL7687130

Cc1ccc(C2=CCN(C(=O)C(C)(C)C)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 6/20 0.53
QDPR P09417 3/20 0.51
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
ALOX15 P16050 2/20 0.46
RAB9A P51151 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 1/20 0.46
KIT P10721 1/20 0.45
KCNH2 Q12809 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14496802 0.83 QDPR (0.70) NAMPTQDPRALDH1A1SMN1; SMN2NPC1
SCHEMBL8912847 0.82 NAMPT (0.63) NAMPTKIT
SCHEMBL23601366 0.80 RIPK1 (0.45) NAMPTQDPRALDH1A1NPC1RAB9A
SCHEMBL16922689 0.79 MEN1 (0.55) NAMPTQDPRALDH1A1SMN1; SMN2NPC1
SCHEMBL24721258 0.78 MMP2 (0.52) NAMPTQDPRALDH1A1SMN1; SMN2NPC1
SCHEMBL16978139 0.76 HDAC6 (0.44) NAMPTQDPRNPC1RAB9AMEN1
SCHEMBL15184569 0.75 ALDH1A1 (0.50) NAMPTQDPRALDH1A1SMN1; SMN2NPC1
SCHEMBL7804408 0.73 PPARA (0.53) NAMPTALDH1A1SMN1; SMN2ALOX15MEN1
SCHEMBL31488994 0.73 NAMPT (0.54) NAMPTQDPRALDH1A1MEN1KMT2A
SCHEMBL17034783 0.72 RIPK1 (0.42) NAMPTQDPRNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6392051-B2 OXIDIZING A 4-PHENYL-N-ACYLDIHYDROPYRIDINE CLARIANT GMBH (DE) 2002-05-21 US disclosed
US-20010021778-A1 Process for preparing 4-(4'-carboxyphenyl)pyridine CLARIANT GMBH 2001-09-13 US disclosed
EP-1125926-A1 Process for the preparation of 4-(4'-carboxyphenyl)pyridine Clariant GmbH (DE) 2001-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010021778-A1 Process for preparing 4-(4'-carboxyphenyl)pyridine NOX4, CBR1, CBR3 NAMPT 2197/4885QDPR 86/4885ALDH1A1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.